Abstract

Methotrexate 2.5-mg Capsules

Author(s): Allen Loyd V Jr

Issue: May/Jun 2014 - Volume 18, Number 3

Page(s): 238

Download in electronic PDF format for $75
  • Methotrexate 2.5-mg Capsules Page 1

Abstract

A formulation for preparing Methotrexate 2.5-mg Capsules. Includes ingredients, method of preparation, discussion, and references for the compounding pharmacist.

Related Keywords

  • methotrexate
  • antimetabolite
  • folic acid antagonist
  • folate inhibitor
  • cancer
  • anticancer agent
  • chemotherapy
  • psoriasis
  • inflammation
  • anti-inflammatory agent

Related Categories

  • CANCER AND AIDS
  • DERMATOLOGY
  • FORMULATIONS
  • MUSCULOSKELETAL DISORDERS

Printer-Friendly Version

Related Articles from IJPC

Issue/Page
View/Buy		 Title/Author
(Click for Abstract / Details / Purchase)
May/Jun 2014
Pg. 238
Methotrexate 2.5-mg Capsules
Author(s): Allen Loyd V Jr
Jul/Aug 2001
Pg. 310-312
Wetting and/or Solubilizing Agents, Featured Excipient:
Author(s): Allen Loyd V Jr
Mar/Apr 2004
Pg. 126-129
Basics of Compounding for the Treatment of Warts
Author(s): Allen Loyd V Jr
Sep/Oct 2013
Pg. 421
Methotrexate 25-mg/mL Injection
Author(s): Allen Loyd V Jr
Mar/Apr 2004
Pg. 101-105
Pluronic Lecithin Organogel for Local Delivery of Anti-Inflammatory Drugs
Author(s): Frankum James, Ramsay Dale, Das Nandita G, Das Sudip K
Jul/Aug 1999
Pg. 309-310
Acidifying Agents, Featured Excipient:
Author(s): Allen Loyd V Jr
Sep/Oct 2015
Pg. 357-365
Novel Approaches to Topical Psoriasis Therapy
Author(s): Koyama Gregory, Liu Jenny, Scaffidi Alyse, Khazraee Maryam, Epstein Benjamin
May/Jun 2004
Pg. 181-185
Compounding in the Pharmacy Curriculum: Beyond the Basics
Author(s): Hinkle Amanda R, Newton Gail D
May/Jun 2019
Pg. 235
Methotrexate 2-mg/mL Oral Solution
Author(s): Allen Loyd V Jr
May/Jun 2017
Pg. 205-211
Management of Psoriasis with a XemaTop Topical Compounded Formula: A Case Report
Author(s): Jones Nat, Carvalho Maria, Branvold-Herr Andrea
Jan/Feb 2003
Pg. 10-15
View Sample
Compounding for the Effects of Weapons of Mass Destruction
Author(s): Sammarco Domenic A
May/Jun 2011
Pg. 204-213
Treatment Options for Psoriasis
Author(s): Williams LaVonn A, Humphreys Erica
Jan/Feb 2011
Pg. 68
Methotrexate 30-mg/g Topical Gel
Author(s): Allen Loyd V Jr
Nov/Dec 1999
Pg. 474
Methotrexate 2.5-mg/5-mL Oral Liquid
Author(s): Allen Loyd V Jr
Nov/Dec 2004
Pg. 462-465
Basics of Compounding for Cough
Author(s): Allen Loyd V Jr
May/Jun 2007
Pg. 244
Folic Acid 1-mg/mL Oral Liquid
Author(s): Allen Loyd V Jr
Nov/Dec 2014
Pg. 497
Leucovorin 10-mg/mL Injection
Author(s): Allen Loyd V Jr
Sep/Oct 2001
Pg. 389-390
Capsule and Tablet Disintegrating Agents, Featured Excipient:
Author(s): Allen Loyd V Jr
May/Jun 2020
Pg. 227
Ibuprofen 400-mg and Cyclobenzaprine 2.5-mg Capsules
Author(s): Allen Loyd V Jr
Nov/Dec 2019
Pg. 504-510
Compatibility of Flavoring Agents in Compounding Extemporaneous Omeprazole Oral Liquid
Author(s): Chuong Monica, Taglieri Catherine A, Huang Szu Yu, Sariol Anthony, Kitigawa Reina, Barman Koushik, Mistry Amee, Harris Donna L, Kerr Stephen G